Marti Flothmann is a Clinical Research Coordinator in the Department of Neurology at the University of Miami, Miller School of Medicine. She received her Bachelor of Science degree from the University of Miami majoring in Exercise Physiology and minoring in sports medicine. She completed a senior internship in the Department of Neurology under the guidance of Dr. Tiozzo, where she decided to continue working in research. Marti has been working with The Bugher study, an AHA funded phase IIa clinical trial investigating the effect of exercise on cognition in post-stroke patients. She has been with the study since 2014, and taken over coordinating the study in April of 2017. She directed the exercise training sessions for research participants, trained new RAs, managed the study’s database, carried out all biospecimen collections and administered the neuropsychological batteries for the study. She has now joined the Evelyn F. McKnight Brain Institute and is managing data and study visits for the McKnight Brain Aging Registry (MBAR) study. Her current research interests include the effects of physical activity on cognitive aging and brain health.
Susan Fox-Rosellini M.B.A. is the Executive Director of Marketing for the Department of Neurology and Marketing and Administration Director for the McKnight Brain Institute and Department of Neurology. She has 35+ years of experience and a proven track record in developing new business and clients, new markets and new products and improving the revenues of for-profit and not-for-profit businesses. She joined the Department of Neurology in 2007 and has successfully tripled the department’s endowment and raised more than $5M annually since 2007. Prior to University of Miami Susan worked as a development leader with the Family Resource Center, the Coconut Grove Playhouse and the Miami City Ballet. She is involved in the arts community and is an expert about silent movies and many of the early film technologies. She wrote a book about the start of Hollywood.
Ralph L. Sacco, M.D., M.S., is the Chairman of Neurology, Olemberg Family Chair in Neurological Disorders, Miller Professor of Neurology, Public Health Sciences, Human Genetics, and Neurosurgery, Executive Director of the Evelyn F. McKnight Brain Institute at the Miller School of Medicine, University of Miami, and Chief of the Neurology Service at Jackson Memorial Hospital.
A graduate of Cornell University in Bio-electrical Engineering and a cum laude graduate of Boston University School of Medicine, he also holds an MS in Epidemiology from Columbia University, Mailman School of Public Health. Dr. Sacco completed his neurology residency training and postdoctoral training in Stroke and Epidemiology at Columbia Presbyterian in New York. He was previously Professor of Neurology, Chief of Stroke and Critical Care Division and Associate Chairman at Columbia University before taking his current position as Chairman of Neurology at the University of Miami, Miller School of Medicine.
He is the founding Principal Investigator of the 26-year NINDS-funded Northern Manhattan Study, the Florida Puerto Rico Collaboration to Reduce Stroke Disparities, and the Family Study of Stroke Risk and Carotid Atherosclerosis, as well as co-investigator of multiple other NIH grants. He has also been the Co-Chair of international stroke treatment and prevention trials. Dr. Sacco has published extensively with 726 articles (H-index of 115) in the areas of stroke prevention, treatment, epidemiology, risk factors, vascular cognitive impairment, brain health, human genetics and stroke recurrence. His research has also addressed health care disparities. He has been the recipient of numerous awards including, the Feinberg Award of Excellence in Clinical Stroke, the Chairman’s Award from the American Heart Association, the NINDS Javits Award in Neuroscience, AAN Wartenberg Lecture Award, and WSO Global Leadership Award. He has lectured extensively at national and international meetings. He served on the National Academy of Medicine panel on Preventing Cognitive Decline and Dementia, 2017, and is an elected member of the NAM.
Dr. Sacco is a fellow of both the Stroke and Epidemiology Councils of the American Heart Association, the American Academy of Neurology, and the American Neurological Association, and serves as the past-President of the American Academy of Neurology. He is also a member of the Association of American Physicians. Dr. Sacco has been a member of the World Stroke Organization since 2008 and is on the Board of Directors. He was the first neurologist to serve as the President of the American Heart Association – 2010-2011.
Dr. Tatjana Rundek is a Professor of Neurology, Epidemiology and Public Health with tenure, Vice Chair of Clinical Research, and Director of the Clinical Translational Research Division in the Department of Neurology of the University of Miami, Miller School of Medicine. She holds a secondary faculty appointment at the Department of Neurology at Columbia University in New York. Dr. Rundek is a stroke neurologist, clinical researcher and principal investigator of several NIH/NINDS funded R01 grants on genetic determinants of carotid atherosclerosis and stroke. Dr. Rundek is a recipient of a NINDS K24 Midcareer development award. She participates in large stroke genetic consortia including the NINDS Stroke Genetic Network and International Stroke Genetic Consortium. Dr. Rundek was a Fulbright Scholar and the recipient of the research awards from the Hazel K. Goddess and the Dr. Gilbert Baum Funds. Dr. Rundek serves on the editorial boards of several scientific journals including Stroke, Neurology, Journal of Ultrasound in Medicine and Cerebrovascular Diseases. She has published over 210 scientific publications, editorials, reviews, and book chapters. She is a fellow of the American Neurological Association, a member of the American Heart Association and American Academy of Neurology. She is past President of the Neurosonology Communities of Practice of the American Institute in Ultrasound in Medicine, the largest professional medical ultrasound organization in the U.S. Dr. Rundek serves on the Intersocietal Accreditation Commission (IAC) Vascular Testing Board of Directors, a national organization that accredits clinical echocardiography, nuclear/PET, MRI, CT and Dental laboratories and carotid stenting programs.
Dr. Bonnie Levin is the Alexandria and Bernard Schoninger Professor of Neurology and Director of the Division of Neuropsychology in the Department of Neurology at the University of Miami, Miller School of Medicine. She received her BS from Georgetown University and her PhD from Temple University. She completed an internship at the Boston Children’s Hospital where she was a clinical fellow in Psychiatry at Harvard Medical School and an externship at the Boston VA Hospital.
Dr. Levin is a neuropsychologist whose research examines neurocognitive and affective changes associated with neurodegenerative disease and the normative aging process. Her work examines the role of cardiometabolic risk factors in cognitive decline. Another focus has been the inter-relationship between behavioral and motor symptoms in Parkinson’s disease and the neural circuitry underlying memory and age related cognitive change. Her current work is aimed to advance our understanding of frontal striatal circuit function in cognition and to generate data that will improve our knowledge of key clinical parameters associated with differential rates of cognitive decline. Current projects include: examining which components of the metabolic syndrome predict cognition, identifying imaging and clinical correlates of white matter changes associated with the aging process and linking structural and metabolic markers underlying different symptom profiles in neurodegenerative disease.